FDA launches pilot to speed up early drug trials and bolster U.S. competitiveness
TL;DR Summary
The FDA announced a pilot to accelerate early-stage clinical trials, aiming to cut development time by six to 12 months, boost U.S.-based trials, and counter China, while seeking congressional support to establish a permanent, faster Investigational New Drug pathway in the 2027 budget; the effort follows advocacy by former FDA Commissioner Marty Makary.
- FDA to launch pilot program to speed up early-stage clinical trials statnews.com
- US FDA updates guidance to speed up drug development Yahoo
- Federal health agencies unveil plan to speed up phase 1 clinical trials by 6 to 12 months Fierce Biotech
- ROBERT F KENNEDY JR: The future of medicine should be built in America AOL.com
- Accelerating and Modernizing Early and Late-Stage Clinical Development fda.gov
Reading Insights
Total Reads
1
Unique Readers
12
Time Saved
2 min
vs 3 min read
Condensed
90%
525 → 53 words
Want the full story? Read the original article
Read on statnews.com